Value-Based Pricing
Value-Based Pricing (VBP) aligns the price of a treatment with the value it provides to patients, healthcare systems, and society. Across multiple indications, a single price may not accurately reflect a medicine’s value, Indication-Based Pricing (IBP) allows different prices to be set for different indications.
An Issues Panel: Developing Cost Effectiveness for Decision Making: What can be Learnt from “Value Based Pricing”?
29 July 2015
This post reports on an Issues Panel which was held at the Spanish Health Economics Association Annual Conference which took place in Granada, Spain 17-19 June…
Do Respondents Completing Abstract, Hypothetical Priority-Setting Exercises Agree with the Policy Implications of Their Choices?
3 March 2015
A new OHE Consulting Report examines whether respondents completing abstract, hypothetical priority-setting exercises in stated preference studies agree with the policy implications of their choices.
Multi-indication Pricing: Pros, Cons and Applicability to the UK
1 October 2015
Multi-indication pricing (MIP) involves setting a different price for each major indication approved for a medicine. As value is likely to differ across major indications, if…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
1 March 2015
A new OHE Consulting Report considers the data capabilities in the UK for monitoring medicine use according to indication using real world data. A new OHE…
OHE at ISPOR Europe: Posters
13 November 2014
The OHE presented the following posters at ISPOR 17th Annual European Congress in Amsterdam, The Netherlands.
OHE at ISPOR Europe 1: Impact of NICE on Innovation and Value
22 October 2014
ISPOR’s 17th Annual European Congress is scheduled for 8-12 November 2014 in Amsterdam. OHE’s Adrian Towse is current President of ISPOR and involved in several sessions.…
Spotlight on OHE: NICE, Biosimilars, HTA
17 June 2014
OHE’s active involvement in a number of recent conferences and meetings has contributed to discussions on a range of important issue in health economics.
Pricing Variations Within and Across Countries: Gauging Efficiency
25 February 2014
This research explores which approaches to pricing can produce the greatest efficiency and access to medicines within and across countries. OHE collaborated on two articles published…
OHE at HESG: Value-based Assessment in the UK; Developing the EQ-5D-5L
23 January 2014
OHE’s contributions focused on approaches to implementing UK value-based assessment and the details of creating an EQ-5D-5L value set for England. The Health Economists’ Study Group…